Pharmaceutical

The pharmaceuticals market is Merxin Ltd’s native land. The team at Merxin Ltd has been working in and for the pharmaceutical industry for decades, designing devices, formulations, planning clinical studies and filings for the treatment of Asthma, COPD, IPAH, cystic fibrosis etc.

We make devices for new molecules (originators) and for generic products. Our DPI and soft mist inhalers are particularly successful with generic developers across the world. Our devices are generic and customised, fulfilling the quality requirements needed for FDA and EMEA scrutiny.

Two Merxin Ltd employees working in the lab

Pharmaceutical Products

The Merxin Ltd device platforms are based on popular and successful original devices designed for combination products (device+formulation) of mono, duo and triple drug formulations. Our devices are perfectly suited for new molecules, and they are available for clinical trials and commercial launch.


MRX003 is a substitutable (AB rated) generic capsule inhaler for tiotropium DPI.

MRX004 is a substitutable (AB rated) generic fine soft mist inhaler for tiotropium or/and olodaterol.

MRX006 is a substitutable (AB rated) generic dual cavity for triple therapy dry powder inhaler.



MRX002+

DESIGNED FOR LOW CARBON FOOTPRINT pMDIS

MRX002+ DESIGNED FOR LOW CARBON FOOTPRINT pMDIS

MRX002+ is a see-through polymer vial ideal for modelling pMDI formulations.

MRX002+ enables carbon neutral inhalers.

MRX002+ is designed for low carbon footprint propellant formulations.

MRX002+ is compatible...

EXPLORE MRX002+

MRX003

Capsule Dry Powder Inhaler

MRX003 Capsule Dry Powder Inhaler

MRX003 is a generic capsule based inhaler designed in particular as a generic AB rated device for tiotropium DPI.

It is developed for new molecules and the...

EXPLORE MRX003

MRX004

Soft mist inhaler

MRX004 Soft mist inhaler

MRX004 is a soft mist inhaler device. It is developed as an interchangeable AB rated device opportunity for tiotropium/olodaterol/

MRX004 is also ideal for life cycle...

EXPLORE MRX004

MRX006

Multidose Dry Powder Inhaler

MRX006 Multidose Dry Powder Inhaler

Dual cavity for triple therapy dry powder inhaler (DPI). MRX006 is based on the open-inhale-close principle. It is suitable as an AB-rated substitutable device for triple combination...

EXPLORE MRX006
Merxin Ltd's DNA is in the pharma industry: delivering quality, reliability and efficacy.
We use cookies only for marketing analytics
Close